{"id":46991,"date":"2022-08-05T16:02:16","date_gmt":"2022-08-05T14:02:16","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/global-behcets-disease-therapeutics-markets-2022-2026-market-is-driven-by-heavy-use-of-off-label-drugs-special-drug-designations-and-increasing-research-funding-for-rare-diseases-researchandmark\/"},"modified":"2022-08-05T16:02:16","modified_gmt":"2022-08-05T14:02:16","slug":"global-behcets-disease-therapeutics-markets-2022-2026-market-is-driven-by-heavy-use-of-off-label-drugs-special-drug-designations-and-increasing-research-funding-for-rare-diseases-researchandmark","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/global-behcets-disease-therapeutics-markets-2022-2026-market-is-driven-by-heavy-use-of-off-label-drugs-special-drug-designations-and-increasing-research-funding-for-rare-diseases-researchandmark\/","title":{"rendered":"Global Behcet&#8217;s Disease Therapeutics Markets 2022-2026: Market is Driven by Heavy Use of Off-Label Drugs, Special Drug Designations, and Increasing Research Funding for Rare Diseases &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5606353\/global-behcets-disease-therapeutics-market-2022?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=9mhpl2&amp;utm_campaign=1735004+-+Global+Behcet%27s+Disease+Therapeutics+Markets+2022-2026%3A+Market+is+Driven+by+Heavy+Use+of+Off-Label+Drugs%2C+Special+Drug+Designations%2C+and+Increasing+Research+Funding+for+Rare+Diseases&amp;utm_exec=chdo54prd\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;Global Behcet&#8217;s Disease Therapeutics Market 2022-2026&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220805005278\/en\/1536449\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220805005278\/en\/1536449\/21\/logo.jpg\"><\/a><\/p>\n<p>\nBehcet&#8217;s disease therapeutics market is poised to grow by $ 281.72 mn during 2022-2026, decelerating at a CAGR of 6.68%\n<\/p>\n<p>\nThe market is driven by heavy use of off-label drugs, special drug designations, and increasing research funding for rare diseases.\n<\/p>\n<p>\nThis study identifies the increasing awareness of rare diseases as one of the prime reasons driving the Behcet&#8217;s disease therapeutics market growth during the next few years. Also, strategic alliances and the advent of novel therapeutics will lead to sizable demand in the market.\n<\/p>\n<p>\nThe report on the Behcet&#8217;s disease therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, challenges, and vendor analysis covering around 25 vendors. The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. Behcet&#8217;s disease therapeutics market analysis includes product segment and geographic landscape.\n<\/p>\n<p>\nThe publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.\n<\/p>\n<p>\nThe publisher&#8217;s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading Behcet&#8217;s disease therapeutics market vendors. This is to help companies strategize and leverage all forthcoming growth opportunities.\n<\/p>\n<p>\nThe study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.\n<\/p>\n<p>\n<strong>Key Topics Covered:<\/strong>\n<\/p>\n<p>\n<strong>1 Executive Summary<\/strong>\n<\/p>\n<p>\n1.1 Market overview\n<\/p>\n<p>\n<strong>2 Market Landscape<\/strong>\n<\/p>\n<p>\n2.1 Market ecosystem\n<\/p>\n<p>\n<strong>3 Market Sizing<\/strong>\n<\/p>\n<p>\n3.1 Market definition\n<\/p>\n<p>\n3.2 Market segment analysis\n<\/p>\n<p>\n3.3 Market size 2021\n<\/p>\n<p>\n3.4 Market outlook: Forecast for 2021-2026\n<\/p>\n<p>\n<strong>4 Five Forces Analysis<\/strong>\n<\/p>\n<p>\n4.1 Five forces summary\n<\/p>\n<p>\n4.2 Bargaining power of buyers\n<\/p>\n<p>\n4.3 Bargaining power of suppliers\n<\/p>\n<p>\n4.4 Threat of new entrants\n<\/p>\n<p>\n4.5 Threat of substitutes\n<\/p>\n<p>\n4.6 Threat of rivalry\n<\/p>\n<p>\n4.7 Market condition\n<\/p>\n<p>\n<strong>5 Market Segmentation by Product<\/strong>\n<\/p>\n<p>\n5.1 Market segments\n<\/p>\n<p>\n5.2 Comparison by Product\n<\/p>\n<p>\n5.3 Small molecules &#8211; Market size and forecast 2021-2026\n<\/p>\n<p>\n5.4 Biologics &#8211; Market size and forecast 2021-2026\n<\/p>\n<p>\n5.5 Market opportunity by Product\n<\/p>\n<p>\n<strong>6 Customer Landscape<\/strong>\n<\/p>\n<p>\n6.1 Customer landscape overview\n<\/p>\n<p>\n<strong>7 Geographic Landscape<\/strong>\n<\/p>\n<p>\n7.1 Geographic segmentation\n<\/p>\n<p>\n7.2 Geographic comparison\n<\/p>\n<p>\n7.3 North America &#8211; Market size and forecast 2021-2026\n<\/p>\n<p>\n7.4 Europe &#8211; Market size and forecast 2021-2026\n<\/p>\n<p>\n7.5 Asia &#8211; Market size and forecast 2021-2026\n<\/p>\n<p>\n7.6 Rest of World (ROW) &#8211; Market size and forecast 2021-2026\n<\/p>\n<p>\n7.7 US &#8211; Market size and forecast 2021-2026\n<\/p>\n<p>\n7.8 Canada &#8211; Market size and forecast 2021-2026\n<\/p>\n<p>\n7.9 UK &#8211; Market size and forecast 2021-2026\n<\/p>\n<p>\n7.10 Germany &#8211; Market size and forecast 2021-2026\n<\/p>\n<p>\n7.11 Japan &#8211; Market size and forecast 2021-2026\n<\/p>\n<p>\n7.12 France &#8211; Market size and forecast 2021-2026\n<\/p>\n<p>\n7.13 Market opportunity By Geographical Landscape\n<\/p>\n<p>\n<strong>8 Drivers, Challenges, and Trends<\/strong>\n<\/p>\n<p>\n<strong>9 Vendor Landscape<\/strong>\n<\/p>\n<p>\n9.1 Overview\n<\/p>\n<p>\n9.2 Vendor landscape\n<\/p>\n<p>\n9.3 Landscape disruption\n<\/p>\n<p>\n9.4 Industry risks\n<\/p>\n<p>\n<strong>10 Vendor Analysis<\/strong>\n<\/p>\n<p>\n10.1 Vendors covered\n<\/p>\n<p>\n10.2 Market positioning of vendors\n<\/p>\n<ul>\n<li>\nAbbVie Inc.\n<\/li>\n<li>\nAmgen Inc.\n<\/li>\n<li>\nF. Hoffmann La Roche Ltd.\n<\/li>\n<li>\nJohnson and Johnson\n<\/li>\n<li>\nMitsubishi Chemical Holdings Corp.\n<\/li>\n<li>\nNovartis AG\n<\/li>\n<li>\nPfizer Inc.\n<\/li>\n<li>\nTakeda Pharmaceutical Co. Ltd.\n<\/li>\n<li>\nViatris Inc.\n<\/li>\n<\/ul>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5606353\/global-behcets-disease-therapeutics-market-2022?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=9mhpl2&amp;utm_campaign=1735004+-+Global+Behcet%27s+Disease+Therapeutics+Markets+2022-2026%3A+Market+is+Driven+by+Heavy+Use+of+Off-Label+Drugs%2C+Special+Drug+Designations%2C+and+Increasing+Research+Funding+for+Rare+Diseases&amp;utm_exec=chdo54prd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/9gggd3<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#x61;i&#x6c;&#x74;&#111;&#x3a;p&#x72;&#x65;&#115;&#x73;&#64;&#x72;&#x65;&#115;&#x65;a&#x72;&#x63;&#104;&#x61;n&#x64;&#x6d;&#97;&#x72;k&#x65;&#x74;&#115;&#x2e;c&#x6f;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#112;&#x72;e&#115;&#x73;&#64;&#114;&#x65;s&#101;&#x61;r&#99;&#x68;a&#110;&#x64;m&#97;&#x72;k&#101;&#x74;s&#46;&#x63;o&#109;<\/a><br \/>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Global Behcet&#8217;s Disease Therapeutics Market 2022-2026&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. Behcet&#8217;s disease therapeutics market is poised to grow by $ 281.72 mn during 2022-2026, decelerating at a CAGR of 6.68% The market is driven by heavy use of off-label drugs, special drug designations, and increasing research funding for rare diseases. &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/global-behcets-disease-therapeutics-markets-2022-2026-market-is-driven-by-heavy-use-of-off-label-drugs-special-drug-designations-and-increasing-research-funding-for-rare-diseases-researchandmark\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-46991","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Global Behcet&#039;s Disease Therapeutics Markets 2022-2026: Market is Driven by Heavy Use of Off-Label Drugs, Special Drug Designations, and Increasing Research Funding for Rare Diseases - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/global-behcets-disease-therapeutics-markets-2022-2026-market-is-driven-by-heavy-use-of-off-label-drugs-special-drug-designations-and-increasing-research-funding-for-rare-diseases-researchandmark\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Global Behcet&#039;s Disease Therapeutics Markets 2022-2026: Market is Driven by Heavy Use of Off-Label Drugs, Special Drug Designations, and Increasing Research Funding for Rare Diseases - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Global Behcet&#8217;s Disease Therapeutics Market 2022-2026&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. Behcet&#8217;s disease therapeutics market is poised to grow by $ 281.72 mn during 2022-2026, decelerating at a CAGR of 6.68% The market is driven by heavy use of off-label drugs, special drug designations, and increasing research funding for rare diseases. ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/global-behcets-disease-therapeutics-markets-2022-2026-market-is-driven-by-heavy-use-of-off-label-drugs-special-drug-designations-and-increasing-research-funding-for-rare-diseases-researchandmark\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-08-05T14:02:16+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220805005278\/en\/1536449\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-behcets-disease-therapeutics-markets-2022-2026-market-is-driven-by-heavy-use-of-off-label-drugs-special-drug-designations-and-increasing-research-funding-for-rare-diseases-researchandmark\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-behcets-disease-therapeutics-markets-2022-2026-market-is-driven-by-heavy-use-of-off-label-drugs-special-drug-designations-and-increasing-research-funding-for-rare-diseases-researchandmark\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Global Behcet&#8217;s Disease Therapeutics Markets 2022-2026: Market is Driven by Heavy Use of Off-Label Drugs, Special Drug Designations, and Increasing Research Funding for Rare Diseases &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2022-08-05T14:02:16+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-behcets-disease-therapeutics-markets-2022-2026-market-is-driven-by-heavy-use-of-off-label-drugs-special-drug-designations-and-increasing-research-funding-for-rare-diseases-researchandmark\\\/\"},\"wordCount\":575,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-behcets-disease-therapeutics-markets-2022-2026-market-is-driven-by-heavy-use-of-off-label-drugs-special-drug-designations-and-increasing-research-funding-for-rare-diseases-researchandmark\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220805005278\\\/en\\\/1536449\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-behcets-disease-therapeutics-markets-2022-2026-market-is-driven-by-heavy-use-of-off-label-drugs-special-drug-designations-and-increasing-research-funding-for-rare-diseases-researchandmark\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-behcets-disease-therapeutics-markets-2022-2026-market-is-driven-by-heavy-use-of-off-label-drugs-special-drug-designations-and-increasing-research-funding-for-rare-diseases-researchandmark\\\/\",\"name\":\"Global Behcet's Disease Therapeutics Markets 2022-2026: Market is Driven by Heavy Use of Off-Label Drugs, Special Drug Designations, and Increasing Research Funding for Rare Diseases - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-behcets-disease-therapeutics-markets-2022-2026-market-is-driven-by-heavy-use-of-off-label-drugs-special-drug-designations-and-increasing-research-funding-for-rare-diseases-researchandmark\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-behcets-disease-therapeutics-markets-2022-2026-market-is-driven-by-heavy-use-of-off-label-drugs-special-drug-designations-and-increasing-research-funding-for-rare-diseases-researchandmark\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220805005278\\\/en\\\/1536449\\\/21\\\/logo.jpg\",\"datePublished\":\"2022-08-05T14:02:16+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-behcets-disease-therapeutics-markets-2022-2026-market-is-driven-by-heavy-use-of-off-label-drugs-special-drug-designations-and-increasing-research-funding-for-rare-diseases-researchandmark\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-behcets-disease-therapeutics-markets-2022-2026-market-is-driven-by-heavy-use-of-off-label-drugs-special-drug-designations-and-increasing-research-funding-for-rare-diseases-researchandmark\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-behcets-disease-therapeutics-markets-2022-2026-market-is-driven-by-heavy-use-of-off-label-drugs-special-drug-designations-and-increasing-research-funding-for-rare-diseases-researchandmark\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220805005278\\\/en\\\/1536449\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220805005278\\\/en\\\/1536449\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-behcets-disease-therapeutics-markets-2022-2026-market-is-driven-by-heavy-use-of-off-label-drugs-special-drug-designations-and-increasing-research-funding-for-rare-diseases-researchandmark\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Global Behcet&#8217;s Disease Therapeutics Markets 2022-2026: Market is Driven by Heavy Use of Off-Label Drugs, Special Drug Designations, and Increasing Research Funding for Rare Diseases &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Global Behcet's Disease Therapeutics Markets 2022-2026: Market is Driven by Heavy Use of Off-Label Drugs, Special Drug Designations, and Increasing Research Funding for Rare Diseases - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/global-behcets-disease-therapeutics-markets-2022-2026-market-is-driven-by-heavy-use-of-off-label-drugs-special-drug-designations-and-increasing-research-funding-for-rare-diseases-researchandmark\/","og_locale":"en_US","og_type":"article","og_title":"Global Behcet's Disease Therapeutics Markets 2022-2026: Market is Driven by Heavy Use of Off-Label Drugs, Special Drug Designations, and Increasing Research Funding for Rare Diseases - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Global Behcet&#8217;s Disease Therapeutics Market 2022-2026&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. Behcet&#8217;s disease therapeutics market is poised to grow by $ 281.72 mn during 2022-2026, decelerating at a CAGR of 6.68% The market is driven by heavy use of off-label drugs, special drug designations, and increasing research funding for rare diseases. ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/global-behcets-disease-therapeutics-markets-2022-2026-market-is-driven-by-heavy-use-of-off-label-drugs-special-drug-designations-and-increasing-research-funding-for-rare-diseases-researchandmark\/","og_site_name":"Pharma Trend","article_published_time":"2022-08-05T14:02:16+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220805005278\/en\/1536449\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/global-behcets-disease-therapeutics-markets-2022-2026-market-is-driven-by-heavy-use-of-off-label-drugs-special-drug-designations-and-increasing-research-funding-for-rare-diseases-researchandmark\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/global-behcets-disease-therapeutics-markets-2022-2026-market-is-driven-by-heavy-use-of-off-label-drugs-special-drug-designations-and-increasing-research-funding-for-rare-diseases-researchandmark\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Global Behcet&#8217;s Disease Therapeutics Markets 2022-2026: Market is Driven by Heavy Use of Off-Label Drugs, Special Drug Designations, and Increasing Research Funding for Rare Diseases &#8211; ResearchAndMarkets.com","datePublished":"2022-08-05T14:02:16+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-behcets-disease-therapeutics-markets-2022-2026-market-is-driven-by-heavy-use-of-off-label-drugs-special-drug-designations-and-increasing-research-funding-for-rare-diseases-researchandmark\/"},"wordCount":575,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-behcets-disease-therapeutics-markets-2022-2026-market-is-driven-by-heavy-use-of-off-label-drugs-special-drug-designations-and-increasing-research-funding-for-rare-diseases-researchandmark\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220805005278\/en\/1536449\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/global-behcets-disease-therapeutics-markets-2022-2026-market-is-driven-by-heavy-use-of-off-label-drugs-special-drug-designations-and-increasing-research-funding-for-rare-diseases-researchandmark\/","url":"https:\/\/pharma-trend.com\/en\/global-behcets-disease-therapeutics-markets-2022-2026-market-is-driven-by-heavy-use-of-off-label-drugs-special-drug-designations-and-increasing-research-funding-for-rare-diseases-researchandmark\/","name":"Global Behcet's Disease Therapeutics Markets 2022-2026: Market is Driven by Heavy Use of Off-Label Drugs, Special Drug Designations, and Increasing Research Funding for Rare Diseases - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-behcets-disease-therapeutics-markets-2022-2026-market-is-driven-by-heavy-use-of-off-label-drugs-special-drug-designations-and-increasing-research-funding-for-rare-diseases-researchandmark\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-behcets-disease-therapeutics-markets-2022-2026-market-is-driven-by-heavy-use-of-off-label-drugs-special-drug-designations-and-increasing-research-funding-for-rare-diseases-researchandmark\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220805005278\/en\/1536449\/21\/logo.jpg","datePublished":"2022-08-05T14:02:16+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/global-behcets-disease-therapeutics-markets-2022-2026-market-is-driven-by-heavy-use-of-off-label-drugs-special-drug-designations-and-increasing-research-funding-for-rare-diseases-researchandmark\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/global-behcets-disease-therapeutics-markets-2022-2026-market-is-driven-by-heavy-use-of-off-label-drugs-special-drug-designations-and-increasing-research-funding-for-rare-diseases-researchandmark\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/global-behcets-disease-therapeutics-markets-2022-2026-market-is-driven-by-heavy-use-of-off-label-drugs-special-drug-designations-and-increasing-research-funding-for-rare-diseases-researchandmark\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220805005278\/en\/1536449\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220805005278\/en\/1536449\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/global-behcets-disease-therapeutics-markets-2022-2026-market-is-driven-by-heavy-use-of-off-label-drugs-special-drug-designations-and-increasing-research-funding-for-rare-diseases-researchandmark\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Global Behcet&#8217;s Disease Therapeutics Markets 2022-2026: Market is Driven by Heavy Use of Off-Label Drugs, Special Drug Designations, and Increasing Research Funding for Rare Diseases &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46991","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=46991"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46991\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=46991"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=46991"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=46991"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}